202 Users Online
Non-Melanoma Skin Cancer Treatment Market Segmented By Radiation Therapy, Chemotherapy, Photodynamic Therapy Treatment with Basal Cell Carcinoma, Squamous Cell Carcinoma Indication
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Non-Melanoma Skin Cancer Treatment Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Epidemiology Analysis
3.4. Pipeline Snapshot
3.5. Reimbursement Scenario
4. North America Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025
4.1. Market Snapshot
4.2. Introduction
4.3. Regional Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Trends
4.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
4.4.1. U.S.
4.4.2. Canada
4.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
4.5.1. U.S.
4.5.2. Canada
4.6. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
4.6.1. Radiation Therapy
4.6.1.1. External Beam Radiation Therapy
4.6.1.2. Electronic Brachytherapy
4.6.1.3. Superficial Radiation Therapy
4.6.2. Chemotherapy
4.6.3. Photodynamic Therapy
4.7. Market Size (US$ Mn) Forecast By Treatment Type, 2017–2025
4.7.1. Radiation Therapy
4.7.1.1. External Beam Radiation Therapy
4.7.1.2. Electronic Brachytherapy
4.7.1.3. Superficial Radiation Therapy
4.7.2. Chemotherapy
4.7.3. Photodynamic Therapy
4.8. Market Size (US$ Mn) Trend Analysis By Indication, 2012–2016
4.8.1. Basal Cell Carcinoma
4.8.2. Squamous Cell Carcinoma
4.9. Market Size (US$ Mn) Forecast By Indication, 2017–2025
4.9.1. Basal Cell Carcinoma
4.9.2. Squamous Cell Carcinoma
4.10. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
4.10.1. Hospitals
4.10.2. Ambulatory Surgical Centers
4.10.3. Specialty Clinics
4.11. Market Size (US$ Mn) Forecast By End User, 2017–2025
4.11.1. Hospitals
4.11.2. Ambulatory Surgical Centers
4.11.3. Specialty Clinics
4.12. Market Attractiveness Analysis
4.12.1. By Country
4.12.2. By Treatment Type
4.12.3. By Indication
4.12.4. By End User
5. Latin America Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025
5.1. Market Snapshot
5.2. Introduction
5.3. Regional Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Trends
5.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
5.4.1. Brazil
5.4.2. Mexico
5.4.3. Rest of Latin America
5.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
5.5.1. Brazil
5.5.2. Mexico
5.5.3. Rest of Latin America
5.6. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
5.6.1. Radiation Therapy
5.6.1.1. External Beam Radiation Therapy
5.6.1.2. Electronic Brachytherapy
5.6.1.3. Superficial Radiation Therapy
5.6.2. Chemotherapy
5.6.3. Photodynamic Therapy
5.7. Market Size (US$ Mn) Forecast By Treatment Type, 2017–2025
5.7.1. Radiation Therapy
5.7.1.1. External Beam Radiation Therapy
5.7.1.2. Electronic Brachytherapy
5.7.1.3. Superficial Radiation Therapy
5.7.2. Chemotherapy
5.7.3. Photodynamic Therapy
5.8. Market Size (US$ Mn) Trend Analysis By Indication, 2012–2016
5.8.1. Basal Cell Carcinoma
5.8.2. Squamous Cell Carcinoma
5.9. Market Size (US$ Mn) Forecast By Indication, 2017–2025
5.9.1. Basal Cell Carcinoma
5.9.2. Squamous Cell Carcinoma
5.10. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
5.10.1. Hospitals
5.10.2. Ambulatory Surgical Centers
5.10.3. Specialty Clinics
5.11. Market Size (US$ Mn) Forecast By End User, 2017–2025
5.11.1. Hospitals
5.11.2. Ambulatory Surgical Centers
5.11.3. Specialty Clinics
5.12. Market Attractiveness Analysis
5.12.1. By Country
5.12.2. By Treatment Type
5.12.3. By Indication
5.12.4. By End User
6. Europe Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025
6.1. Market Snapshot
6.2. Introduction
6.3. Regional Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Trends
6.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Rest of Europe
6.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
6.5.1. Germany
6.5.2. France
6.5.3. U.K.
6.5.4. Italy
6.5.5. Spain
6.5.6. Rest of Europe
6.6. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
6.6.1. Radiation Therapy
6.6.1.1. External Beam Radiation Therapy
6.6.1.2. Electronic Brachytherapy
6.6.1.3. Superficial Radiation Therapy
6.6.2. Chemotherapy
6.6.3. Photodynamic Therapy
6.7. Market Size (US$ Mn) Forecast By Treatment Type, 2017–2025
6.7.1. Radiation Therapy
6.7.1.1. External Beam Radiation Therapy
6.7.1.2. Electronic Brachytherapy
6.7.1.3. Superficial Radiation Therapy
6.7.2. Chemotherapy
6.7.3. Photodynamic Therapy
6.8. Market Size (US$ Mn) Trend Analysis By Indication, 2012–2016
6.8.1. Basal Cell Carcinoma
6.8.2. Squamous Cell Carcinoma
6.9. Market Size (US$ Mn) Forecast By Indication, 2017–2025
6.9.1. Basal Cell Carcinoma
6.9.2. Squamous Cell Carcinoma
6.10. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
6.10.1. Hospitals
6.10.2. Ambulatory Surgical Centers
6.10.3. Specialty Clinics
6.11. Market Size (US$ Mn) Forecast By End User, 2017–2025
6.11.1. Hospitals
6.11.2. Ambulatory Surgical Centers
6.11.3. Specialty Clinics
6.12. Market Attractiveness Analysis
6.12.1. By Country
6.12.2. By Treatment Type
6.12.3. By Indication
6.12.4. By End User
7. Asia Pacific Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025
7.1. Market Snapshot
7.2. Introduction
7.3. Regional Market Dynamics
7.3.1. Drivers
7.3.2. Restraints
7.3.3. Trends
7.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
7.4.1. China
7.4.2. India
7.4.3. Japan
7.4.4. Australia and New Zealand
7.4.5. Rest of Asia Pacific
7.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
7.5.1. China
7.5.2. India
7.5.3. Japan
7.5.4. Australia and New Zealand
7.5.5. Rest of Asia Pacific
7.6. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
7.6.1. Radiation Therapy
7.6.1.1. External Beam Radiation Therapy
7.6.1.2. Electronic Brachytherapy
7.6.1.3. Superficial Radiation Therapy
7.6.2. Chemotherapy
7.6.3. Photodynamic Therapy
7.7. Market Size (US$ Mn) Forecast By Treatment Type, 2017–2025
7.7.1. Radiation Therapy
7.7.1.1. External Beam Radiation Therapy
7.7.1.2. Electronic Brachytherapy
7.7.1.3. Superficial Radiation Therapy
7.7.2. Chemotherapy
7.7.3. Photodynamic Therapy
7.8. Market Size (US$ Mn) Trend Analysis By Indication, 2012–2016
7.8.1. Basal Cell Carcinoma
7.8.2. Squamous Cell Carcinoma
7.9. Market Size (US$ Mn) Forecast By Indication, 2017–2025
7.9.1. Basal Cell Carcinoma
7.9.2. Squamous Cell Carcinoma
7.10. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
7.10.1. Hospitals
7.10.2. Ambulatory Surgical Centers
7.10.3. Specialty Clinics
7.11. Market Size (US$ Mn) Forecast By End User, 2017–2025
7.11.1. Hospitals
7.11.2. Ambulatory Surgical Centers
7.11.3. Specialty Clinics
7.12. Market Attractiveness Analysis
7.12.1. By Country
7.12.2. By Treatment Type
7.12.3. By Indication
7.12.4. By End User
8. Middle East & Africa Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025
8.1. Market Snapshot
8.2. Introduction
8.3. Regional Market Dynamics
8.3.1. Drivers
8.3.2. Restraints
8.3.3. Trends
8.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
8.4.1. South Africa
8.4.2. GCC Countries
8.4.3. Turkey
8.4.4. Rest of MEA
8.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
8.5.1. South Africa
8.5.2. GCC Countries
8.5.3. Turkey
8.5.4. Rest of MEA
8.6. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
8.6.1. Radiation Therapy
8.6.1.1. External Beam Radiation Therapy
8.6.1.2. Electronic Brachytherapy
8.6.1.3. Superficial Radiation Therapy
8.6.2. Chemotherapy
8.6.3. Photodynamic Therapy
8.7. Market Size (US$ Mn) Forecast By Treatment Type, 2017–2025
8.7.1. Radiation Therapy
8.7.1.1. External Beam Radiation Therapy
8.7.1.2. Electronic Brachytherapy
8.7.1.3. Superficial Radiation Therapy
8.7.2. Chemotherapy
8.7.3. Photodynamic Therapy
8.8. Market Size (US$ Mn) Trend Analysis By Indication, 2012–2016
8.8.1. Basal Cell Carcinoma
8.8.2. Squamous Cell Carcinoma
8.9. Market Size (US$ Mn) Forecast By Indication, 2017–2025
8.9.1. Basal Cell Carcinoma
8.9.2. Squamous Cell Carcinoma
8.10. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
8.10.1. Hospitals
8.10.2. Ambulatory Surgical Centers
8.10.3. Specialty Clinics
8.11. Market Size (US$ Mn) Forecast By End User, 2017–2025
8.11.1. Hospitals
8.11.2. Ambulatory Surgical Centers
8.11.3. Specialty Clinics
8.12. Market Attractiveness Analysis
8.12.1. By Country
8.12.2. By Treatment Type
8.12.3. By Indication
8.12.4. By End User
9. Competition Landscape
9.1. Competition Dashboard
9.2. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
9.2.1. Almirall S.A.
9.2.2. Boehringer Ingelheim GmbH
9.2.3. Bristol-Myers Squibb Company
9.2.4. Eli Lilly and Company
9.2.5. Elekta AB
9.2.6. F. Hoffmann-La Roche Ltd.
9.2.7. Merck & Co., Inc.
9.2.8. Novartis AG
9.2.9. Mylan NV
9.2.10. Sun Pharmaceutical Industries Ltd.
9.2.11. Varian Medical Systems, Inc.
9.2.12. Sensus Healthcare
9.2.13. iCAD, Inc.
9.2.14. Accuray, Inc.
9.2.15. Ion Beam Applications SA
10. Global Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Region
10.1. Introduction/Key Findings
10.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
10.2.1. North America
10.2.2. Latin America
10.2.3. Europe
10.2.4. Asia Pacific
10.2.5. Middle East & Africa
10.3. Market Size (US$ Mn) Forecast By Region, 2017–2025
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East & Africa
10.4. Market Attractiveness Analysis By Region
11. Global Non-Melanoma Skin Cancer Treatment Analysis 2012–2016 and Forecast 2017–2025, By Treatment Type
11.1. Introduction/Key Findings
11.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Treatment Type, 2012–2016
11.2.1. Radiation Therapy
11.2.1.1. External Beam Radiation Therapy
11.2.1.2. Electronic Brachytherapy
11.2.1.3. Superficial Radiation Therapy
11.2.2. Chemotherapy
11.2.3. Photodynamic Therapy
11.3. Market Size (US$ Mn) and Volume Forecast By Treatment Type, 2017–2025
11.3.1. Radiation Therapy
11.3.1.1. External Beam Radiation Therapy
11.3.1.2. Electronic Brachytherapy
11.3.1.3. Superficial Radiation Therapy
11.3.2. Chemotherapy
11.3.3. Photodynamic Therapy
11.4. Market Attractiveness Analysis By Treatment Type
12. Global Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Indication
12.1. Introduction/Key Findings
12.2. Historical Market Size (US$ Mn) Trend Analysis By Indication , 2012–2016
12.2.1. Basal Cell Carcinoma
12.2.2. Squamous Cell Carcinoma
12.3. Market Size (US$ Mn) Forecast By Indication , 2017–2025
12.3.1. Basal Cell Carcinoma
12.3.2. Squamous Cell Carcinoma
12.4. Market Attractiveness Analysis By Indication
13. Global Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By End User
13.1. Introduction/Key Findings
13.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
13.2.1. Hospitals
13.2.2. Ambulatory Surgical Centers
13.2.3. Specialty Clinics
13.3. Market Size (US$ Mn) Forecast By End User, 2017–2025
13.3.1. Hospitals
13.3.2. Ambulatory Surgical Centers
13.3.3. Specialty Clinics
13.4. Market Attractiveness Analysis By End User
14. Global Non-Melanoma Skin Cancer Treatment Market Analysis 2012–2016 and Forecast 2017–2025
14.1. Market Size and Y-o-Y Growth
14.2. Absolute $ Opportunity
15. Assumptions and Acronyms Used
16. Research Methodology
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Table 01: North America Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 02: North America Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Treatment Type
Table 03: North America Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
Table 04: North America Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 05: Latin America Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 06: Latin America Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Treatment Type
Table 07: Latin America Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
Table 08: Latin America Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 09: Europe Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 10: Europe Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Treatment Type
Table 11: Europe Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
Table 12: Europe Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 13: Asia-Pacific Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 14: Asia Pacific Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Treatment Type
Table 15: Asia-Pacific Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
Table 16: Asia-Pacific Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 17: MEA Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 18: MEA Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Treatment Type
Table 19: MEA NMSC Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
Table 20: MEA Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 21: Global Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Region
Table 22: Global Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Treatment Type
Table 23: Global Non-Melanoma Skin Cancer Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
Table 24: Global Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By End User,
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
Figure 01: Non-Melanoma Skin Cancer Treatment Market Split By Treatment Type (2017)
Figure 02: Non-Melanoma Skin Cancer Treatment Market Split By Indication (2017)
Figure 03: Non-Melanoma Skin Cancer Treatment Market Split By End User (2017)
Figure 04: Non-Melanoma Skin Cancer Treatment Market Split By Region (2017)
Figure 05: Non-Melanoma Skin Cancer Treatment Market Split By Treatment Type (2017)
Figure 06: Non-Melanoma Skin Cancer Treatment Market Split By Indication (2017)
Figure 07: Non-Melanoma Skin Cancer Treatment Market Split By End User (2017)
Figure 08: Non-Melanoma Skin Cancer Treatment Market Split By Region (2017)
Figure 09: North America Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 10: North America Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 11: U.S. Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 12: U.S. Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 13: Canada Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 14: Canada Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 15: North America Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By Treatment Type
Figure 16: North America Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By Indication
Figure 17: North America Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By End User
Figure 18: North America Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By Country
Figure 19: Non-Melanoma Skin Cancer Treatment Market Split By Treatment Type (2017)
Figure 20: Non-Melanoma Skin Cancer Treatment Market Split By Indication (2017)
Figure 21: Non-Melanoma Skin Cancer Treatment Market Split By End User (2017)
Figure 22: Non-Melanoma Skin Cancer Treatment Market Split By Region (2017)
Figure 23: Latin America Non-Melanoma Skin Cancer Treatment Market Size Analysis, 2012–2016
Figure 24: Latin America Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 25: Brazil Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 26: Brazil Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 27: Mexico Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 28: Mexico Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 29: Rest of Latin America Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 30: Rest of Latin America NMSC Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 31: Latin America Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By Treatment Type
Figure 32: Latin America Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By Indication
Figure 33: Latin America Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By End User
Figure 34: Latin America Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By Country
Figure 35: Non-Melanoma Skin Cancer Treatment Market Split By Treatment Type (2017)
Figure 36: Non-Melanoma Skin Cancer Treatment Market Split By Indication (2017)
Figure 37: Non-Melanoma Skin Cancer Treatment Market Split By End User (2017)
Figure 38: Non-Melanoma Skin Cancer Treatment Market Split By Region (2017)
Figure 39: Europe Non-Melanoma Skin Cancer Treatment Market Size Analysis, 2012–2016
Figure 40: Europe Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 41: Germany Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 42: Germany Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 43: France Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 44: France Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 45: U.K Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 46: U.K Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 47: Italy Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 48: Italy Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 49: Spain Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 50: Spain Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 51: Rest of Europe Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 52: Rest of Europe Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 53: Europe Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By Treatment Type
Figure 54: Europe Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By Indication
Figure 55: Europe Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By End User
Figure 56: Europe Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By Country
Figure 57: Non-Melanoma Skin Cancer Treatment Market Split By Treatment Type (2017)
Figure 58: Non-Melanoma Skin Cancer Treatment Market Split By Indication (2017)
Figure 59: Non-Melanoma Skin Cancer Treatment Market Split By End User (2017)
Figure 60: Non-Melanoma Skin Cancer Treatment Market Split By Region (2017)
Figure 61: Asia-Pacific Non-Melanoma Skin Cancer Treatment Market Size Analysis, 2012–2016
Figure 62: Asia-Pacific Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 63: China Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 64: China Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 65: India Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 66: India Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 67: Japan Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 68: Japan Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 69: Australia & New Zealand Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 70: Australia & New Zealand Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 71: Rest of APAC Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 72: Rest of APAC Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 73: Asia-Pacific Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By Treatment Type
Figure 74: Asia-Pacific Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By Indication
Figure 75: Asia-Pacific Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By End User
Figure 76: Asia-Pacific Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By Country
Figure 77: Non-Melanoma Skin Cancer Treatment Market Split By Treatment Type (2017)
Figure 78: Non-Melanoma Skin Cancer Treatment Market Split By Indication (2017)
Figure 79: Non-Melanoma Skin Cancer Treatment Market Split By End User (2017)
Figure 80: Non-Melanoma Skin Cancer Treatment Market Split By Region (2017)
Figure 81: MEA Non-Melanoma Skin Cancer Treatment Market Size Analysis, 2012–2016
Figure 82: MEA Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 83: South Africa Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 84: South Africa Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 85: GCC Countries Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 86: GCC Countries Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 87: Turkey Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 88: Turkey Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 89: Rest of MEA Non-Melanoma Skin Cancer Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 90: Rest of MEA Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 91: MEA Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By Treatment Type
Figure 92: MEA Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By Indication
Figure 93: MEA Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By End User
Figure 94: MEA Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis, By Country
Figure 95: Global NMSC Treatment Market Share Analysis (%) By Region, 2017 & 2025
Figure 96: Global NMSC Treatment Market Y-o-Y Growth (%) By Region, 2016–2025
Figure 97: Global Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis By Region, 2017–2025
Figure 98: Global NMSC Treatment Market Share Analysis (%) By Treatment Type, 2017 & 2025
Figure 99: Global NMSC Treatment Market Y-o-Y Growth (%) By Treatment Type, 2016–2025
Figure 100: Global Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis By Treatment Type , 2017–2025
Figure 101: Global NMSC Treatment Market Share Analysis (%) By Drug Indication, 2017 & 2025
Figure 102: Global NMSC Treatment Market Y-o-Y Growth (%) By Drug Indication, 2016–2025
Figure 103: Global Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis By Drug Indication, 2017–2025
Figure 104: Global NMSC Treatment Market Share Analysis (%) By End User, 2017 & 2025
Figure 105: Global NMSC Treatment Market Y-o-Y Growth (%) By End User, 2016–2025
Figure 106: Global Non-Melanoma Skin Cancer Treatment Market Attractiveness Analysis By End User, 2017–2025
Figure 107: Global Non-Melanoma Skin Cancer Treatment Market Value Analysis and Forecast, 2016–2025 (US$ Mn)
Figure 108: Global Non-Melanoma Skin Cancer Treatment Market Value (US$ Mn), 2012–2016
Figure 109: Global Non-Melanoma Skin Cancer Treatment Market Absolute $ Opportunity (US$ Mn), 2016–2025
